Nexcelom Bioscience makes image cytometry products for life science and biomedical research, including cell viability counters.
Founded in 2003 and based in Massachusetts, US, Nexcelom Bioscience has approximately 130 employees with offices in the US, UK and China. Its cytometry products support drug discovery, development and manufacturing, ranging from cell viability counters to high-throughput microwell image cytometry workstations. The company is set to become part of PerkinElmer, Inc. as of May 2021, which is expected to help academic, government and biopharmaceutical customers speed up their workflows.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in